Overview

Long-term Effects of Imiquimod and Diclofenac in Actinic Keratoses

Status:
Completed
Trial end date:
2012-11-01
Target enrollment:
Participant gender:
Summary
This clinical trial serves the purpose to compare the long-term effects of a treatment of actinic keratosis - your skin disorder - using Aldara® 5% cream or Solaraze® 3% gel on the face or the scalp. In particular, it should be found out whether the healing effect of these two medications on the skin lesions (i.e. the damaged skin parts) can be maintained for a prolonged period.
Phase:
Phase 4
Details
Lead Sponsor:
MEDA Pharma GmbH & Co. KG
Treatments:
Diclofenac
Imiquimod